Overview
Carrie Kitko is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee.
Dr. Kitko is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Febrile Neutropenia, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.
She is actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 13 clinical trials. Dr. Kitko is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
2200 Childrens Way Fl 6, Nashville, TN 37232
Additional Areas of Focus
Dr. Kitko has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
Vanderbilt Children's Hematology-Oncology
Michael Debaun is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Debaun is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Debaun is currently accepting new patients.
Tennessee Oncology, PLLC-#412 25th Ave
Ian Flinn is an Oncologist practicing medicine in Nashville, Tennessee. Dr. Flinn is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Flinn is board certified in The American Board Of Internal Medicine - Hematology. Dr. Flinn is currently accepting new patients.
Vanderbilt Children's Hematology-Oncology
James Connelly is a Hematologist and an Oncologist practicing medicine in Nashville, Tennessee. Dr. Connelly is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Agranulocytosis, Chronic Familial Neutropenia, Severe Congenital Neutropenia, Bone Marrow Transplant, and Splenectomy. Dr. Connelly is currently accepting new patients.
Frequently Asked Questions about Dr. Carrie L. Kitko
How do I make an appointment with Dr. Carrie L. Kitko?
You can book an appointment with Dr. Carrie L. Kitko by calling their office at 615-322-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Carrie L. Kitko a top-rated expert for Graft Versus Host Disease (GvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Carrie L. Kitko is classified as an Elite expert for Graft Versus Host Disease (GvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Carrie L. Kitko specialize in?
While Dr. Carrie L. Kitko is a Hematology, they have specific expertise in Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Carrie L. Kitko participate in research or clinical trials?
Yes. Dr. Carrie L. Kitko has published 130 articles and abstracts on conditions like Graft Versus Host Disease (GvHD). You can view a list of Dr. Carrie L. Kitko's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Carrie L. Kitko accept my insurance?
Dr. Carrie L. Kitko accepts most major insurance plans, including Alliant Health and Blue Cross Blue Shield. We recommend calling the office directly at 615-322-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Graft Versus Host Disease (cGvHD)
- Graft Versus Host Disease (GvHD)
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Bone Marrow TransplantDr. Kitko isAdvanced. Learn about Bone Marrow Transplant.
- Febrile NeutropeniaDr. Kitko isAdvanced. Learn about Febrile Neutropenia.
- LeukemiaDr. Kitko isAdvanced. Learn about Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Kitko isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaDr. Kitko isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Kitko isExperienced. Learn about Agranulocytosis.
- AnemiaDr. Kitko isExperienced. Learn about Anemia.
- Burkitt LymphomaDr. Kitko isExperienced. Learn about Burkitt Lymphoma.
- Congenital Hemolytic AnemiaDr. Kitko isExperienced. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Kitko isExperienced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Kitko isExperienced. Learn about Hemolytic Anemia.
- Myelodysplastic Syndrome (MDS)Dr. Kitko isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaDr. Kitko isExperienced. Learn about Non-Hodgkin Lymphoma.
- Sickle Cell DiseaseDr. Kitko isExperienced. Learn about Sickle Cell Disease.